Diagnostic and Management Pathways for Pulmonary Carcinoid Tumours in the United Kingdom: Results from the National Lung Neuroendocrine Tumour Pathway Project

Figure 3

Reported use of tests and investigations at diagnosis in CoE vs. non-CoE respondents. Any version. Bars represent the percentage of respondents reporting use of tests / investigations at their centre; the remainder reported either ‘no’ (i.e., test not used) or ‘not known.’ Abbreviations: 5-HIAA, 5-hydroxyindoleacetic acid; CoE, Centre of Excellence; CT TAP, computed tomography of thorax, abdomen and pelvis; FDG, fluorodeoxyglucose; PET, positron emission tomography; SRS, somatostatin receptor scintigraphy; TNM, Tumour Node Metastasis; WHO, World Health Organisation.